Founded PharmGenomics GmbH in 2008, focused on the development of innovative methodologies for the detection of genetic variants.
Led PharmGenomics as co-CEO and CSO since 2008
As CSO at PharmGenomics, responsible for the research and development of several innovative products.
Managed several national and international consortial grant projects with large industrial or academic partners.
Responsible for various financing rounds of PharmGenomics GmbH with national and international well-reputed Banks such as KfW, Bonn, Germany and diverse business angels.
